Kaiser Health News

Across the board, hospitals earned more if they were in a state where more people had coverage and saw declines in the level of uncompensated care.

Rising concerns about spending on prescription drugs that treat rare diseases are not justified, according to a new analysis in the journal Health Affairs.

As the Zika virus spreads both at home and abroad, new information is bringing to light how children, even those who at birth do not show obvious signs of impairment, are likely at a greater risk than previously believed.

Several states now require insurers to keep directories updated at least every quarter, among other guidelines.

As of July 1, the FDA had 4,036 generic drug applications awaiting approval; median time it takes for the FDA to approve a generic is now 47 months.

Nearly 20 percent of Medicare patients return to the hospital within 30 days, costing more than $26 billion annually, federal data shows.

Research suggests that "implicit bias" -- doctors and nurses subtly or subconsciously treating some patients differently than others -- or patients' perception of it could have consequences for people's health.

Six new standardized plan designs will eliminate many of the moving parts that have bedeviled consumers trying to make apples-to-apples comparisons between plans.

Separate study says 45 percent may be a low estimate and number could be closer to 65 percent.

Mylan said Monday it will offer a generic version of the life-saving allergy treatment following weeks of criticism over price hike.